To the best of our knowledge, this is the first report to demonstrate a critical role for HOTAIR in cisplatin-induced cachexia in bladder cancer and to identify HOTAIR as a new therapeutic target for cachexia in bladder cancer and likely other cancers. The gene discussed is HOTAIR; the disease is urinary bladder cancer.